The 1st World Congress was held in June 2011 at Zentralklinik, Bad Berka, Germany. Our aim has been to broaden the understanding of the rapidly developing research and clinical applications of Ga-68 and other generator-produced PET radioisotopes, new PET radiopharmaceuticals as well as PRRNT. Our hope is to educate and to offer a unique forum for high level scientific discussions on the recent developments in the exciting field of THERANOSTICS.
SInce the time of the 1st World Congress the use Ga68 Pet/CT imaging has grown tremendously as highlighted in the map above. Click on the map for a real time update of centers that have Ga68 in clinical trials or are using it in a production setting.
Our Congresses include outstanding speakers from all over the world giving insights into their research and clinical work, creating new ideas and concepts on the way to personalized medicine.
We look forward to seeing you at the Fourth Theranostics World Congress (4TWC) in Melbourne, Australia, November 6-8, 2016 at The Peter MacCallum Cancer Centre. Please join our mailing list to be kept updated.
The 3rd Theranostics World Congress (3TWC) took place on the campus of Johns Hopkins University on March 12-14, 2015.
The Congress, Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and Johns Hopkins Medicine, was intended for chemists, physicists, technologists, physicians and all scientists and clinicians interested in translational research and current state-of-the-art molecular imaging using 68Ga PET radiopharmaceuticals and radionuclide therapy. The increase in enthusiasm for 68Ga use over the last several years can be ascribed to several factors, some of which promise an increasing role for 68Ga as a tool in both diagnostic and therapeutic applications such as theranostics. The term "theranostics" symbolizes the inseparability of diagnosis and therapy and has a profound effect personalized disease management. To view all the videos please visit our vimeo channel by clicking here.